1. Home
  2. XBIO vs OLOX Comparison

XBIO vs OLOX Comparison

Compare XBIO & OLOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.15

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Logo Olenox Industries Inc. Common Stock

OLOX

Olenox Industries Inc. Common Stock

N/A

Current Price

$4.77

Market Cap

6.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIO
OLOX
Founded
N/A
2007
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
6.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBIO
OLOX
Price
$3.15
$4.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.2K
302.1K
Earning Date
05-13-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.81
$1,628.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.45
52 Week High
$13.93
$5.75

Technical Indicators

Market Signals
Indicator
XBIO
OLOX
Relative Strength Index (RSI) 53.48 91.88
Support Level $2.94 $0.62
Resistance Level $3.69 N/A
Average True Range (ATR) 0.15 0.21
MACD -0.02 0.42
Stochastic Oscillator 52.38 81.52

Price Performance

Historical Comparison
XBIO
OLOX

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About OLOX Olenox Industries Inc. Common Stock

Olenox Industries Inc is an industrial holding company focused on acquiring, operating, and scaling businesses that provide engineered solutions across industrial, energy, and infrastructure markets. Through its subsidiaries, it delivers high-quality modular and containerized systems designed for rapid deployment and long-term performance.

Share on Social Networks: